symmetric dimethylarginine has been researched along with Polycystic Ovarian Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, WP; Heresztyn, T; Horowitz, JD; Liberts, EA; Marber, MS; Norman, RJ; Rajendran, S; Saha, M; Willoughby, SR | 1 |
Barry, JA; Hardiman, PJ; Kay, AR; Lakhani, K; Leiper, J | 1 |
2 other study(ies) available for symmetric dimethylarginine and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.
Topics: Adenosine Diphosphate; Adult; Albuterol; Arginine; Body Composition; C-Reactive Protein; Cohort Studies; Endothelial Cells; Endothelium, Vascular; Female; Humans; Inflammation Mediators; Malondialdehyde; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Nitroprusside; Obesity; Oxidative Stress; Platelet Aggregation; Platelet Function Tests; Polycystic Ovary Syndrome; Stem Cells; Time Factors; Vasodilator Agents | 2009 |
Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: a pilot study.
Topics: Adult; Androgens; Anthropometry; Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Insulin; Kidney; Pilot Projects; Polycystic Ovary Syndrome; Young Adult | 2011 |